Concepedia
Statistics
Publications
53
Citations
3.5K
H-Index
31
Active since
1993
Affiliations
Nagoya University(Current)
Nagoya Medical Center
National Hospital Organization
Nagoya University Hospital
Otsuka (Japan)
Fumihiko Hayakawa is an author at Nagoya University specializing in molecular oncology, medicine, and oncology.
Publications per year
1993–2022
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
Fumihiko Hayakawa, Masayuki Towatari, Hitoshi Kiyoi et al. · Oncogene · 2000 · 576 citations
Life Sciences, Cell Biology, Genetics +8
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
Jianfeng Li, Yuting Dai, Henrik Lilljebjörn et al. · Proceedings of the National Academy of Sciences · 2018 · 321 citations · Full text
Life Sciences, Genetics, Hematology +17
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations
Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda et al. · Blood · 2017 · 148 citations
Medicine, Oncology, Chemotherapy +7
Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells
Nobuaki Fukushima, Yosuke Minami, Seiji Kakiuchi et al. · Cancer Science · 2016 · 144 citations · Full text
Medicine, Oncology, Pharmacology +17
Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis
Fumihiko Hayakawa, Martin L. Privalsky · Cancer Cell · 2004 · 136 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
1–5 of 53